首页> 外文期刊>Ukrainian Biochemical Journal >Study of rat blood serum biochemical indicators of cardiotoxic action of novel antitumor 4-thiazolidinone derivatives and doxorubicin in complexes with polyethylenglycol-containing polymeric carrier in the rat blood serum
【24h】

Study of rat blood serum biochemical indicators of cardiotoxic action of novel antitumor 4-thiazolidinone derivatives and doxorubicin in complexes with polyethylenglycol-containing polymeric carrier in the rat blood serum

机译:新型抗肿瘤4-噻唑烷酮衍生物和阿霉素与含聚乙二醇的聚合物载体复合的大鼠血清中大鼠心脏毒性的生化指标研究

获取原文
           

摘要

The aim of this study was to measure the activity of enzymes which reflect cardiotoxic action in rats of novel synthetic 4-thiazolidone derivatives – 3882, 3288 and 3833 that demonstrated antineoplastic effect in vitro towards 60 lines of human tumor cells tested in the framework of the program of screening new anticancer drugs at the National Cancer Institute (USA). Such action of these compounds was compared with the effect of well known anticancer agent doxorubicin and after conjugation of all above mentioned substances with new polyethylenglycol-containing polymeric comb-like carrier that was synthesized by the authors. Among the biochemical indicators of cardiotoxic action of anticancer agents, activity of the following enzymes in rat blood serum showed to be the most informative: creatine kinase, lactate dehydrogenase, aspartate aminotransferase, and alanine aminotransferase. Tenfold injection of doxorubicin in a dose of 5.5 mg/kg of weight caused rats’ death, while 3882, 3288 and 3833 preparations had not such action. Application of the doxorubicin in combination with polymeric carrier prolonged the survival time to 20 days. Thus, the injection of anticancer agents in a complex with polymeric carrier provides a significant decrease in their cardiotoxicity that was confirmed by the corresponding changes in the activity of marker enzymes: creatine kinase, lactate dehydrogenase, aspartate aminotransferase and alanine aminotransferase in blood serum of treated rats.
机译:这项研究的目的是测量在新型合成的4-噻唑烷酮衍生物– 3882、3288和3833大鼠中反映心脏毒性作用的酶的活性,这些衍生物在体外对60株人类肿瘤细胞进行了抗肿瘤作用。美国国家癌症研究所筛查新的抗癌药物的计划。将这些化合物的这种作用与众所周知的抗癌药阿霉素的作用进行了比较,并在所有上述物质与作者合成的新型含聚乙二醇的聚合梳状载体结合后进行了比较。在抗癌药心脏毒性作用的生化指标中,大鼠血清中以下酶的活性被证明是最有用的:肌酸激酶,乳酸脱氢酶,天冬氨酸转氨酶和丙氨酸转氨酶。以5.5 mg / kg的体重十倍注射阿霉素可导致大鼠死亡,而3882、3288和3833制剂则没有这种作用。阿霉素与聚合物载体联合应用可将生存时间延长至20天。因此,在与聚合物载体复合物中注射抗癌剂可显着降低其心脏毒性,这一点可通过所治疗血清中标记酶(肌酸激酶,乳酸脱氢酶,天冬氨酸转氨酶和丙氨酸转氨酶)活性的相应变化来证实大鼠。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号